Covid-19 vaccine candidate Covaxin, AIIMS Director Dr Randeep Guleria said the trial will be conducted in three phases. A total of 1,125 samples have been collected, which will be used for trials in the first two phases, he added."Phase 1 vaccine trial will be conducted on healthy people aged 18-55 years who have no co-morbidity.
A total of 1125 samples have been collected of which 375 people will be studied in the first phase and 750 people between 12-65 years will be studied in the second phase," said Guleria."To test the efficacy and effectiveness of the vaccine a trial will be conducted under phase-3.
The trail will be conducted in AIIMS," he added."Launching of vaccine depends on its overall trial, we will have check the effectiveness.